Bacteremia due to Campylobacter fetus isolated by conventional methods from an immunocompromised patient;Bacteriemia por Campylobacter fetus aislado mediante métodos convencionales de una paciente inmunocomprometida

Revista Argentina de Microbiologia

Volumn 39, Issue 1, 2007, Pages 34-37

  Epifane, G ^a   Barbon, S ^a   Sadino, G ^a   Bouchet, D ^a   Suarez M E ^b   Mangiaterra, S ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b Hospital de Ninos de la Santisima Trinidad   (Argentina)

Author keywords

Bacteremia; Campylobacter fetus; Immunocompromised

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD CULTURE; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOODY DIARRHEA; BREAST CANCER; CAMPYLOBACTER FETUS; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; PANCYTOPENIA; PROMYELOCYTIC LEUKEMIA; UNCONSCIOUSNESS; URINALYSIS;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; CAMPYLOBACTER FETUS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED;

EID: 34248186179     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Blaser M. Campylobacter fetus emerging infection and model system for bacterial pathogenesis at mucosal surfaces. Clin Infect Dis 1998; 27: 256-8.
2. Briedis D, Khamesan A, McLaughlin R, Vali H, Panaritou M, Chan E. Isolation of Campylobacter fetus subsp. fetus from patient with cellulitis. J Clin Microbiol 2002; 40: 4792-6.
3. Chuman Y, Takata T, Sameshima H, Takeuchi S, Takatsuka Y, Makino T, et al. Campylobacter fetus bacteremia in a patient with adult cell leukemia. Clin Infect Dis 2003; 36: 1497-8.
4. Clinical and Laboratory Standards Institute. Disk diffusion. Performance standards for antimicrobial susceptibility testing; 15th informational supplement, 2005; M100-S15. Wayne, Pa, USA.
5. Gaudreau C, Gilbert H. Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. Antimicrob Agents Chemother 1998; 42: 2106-8.
6. Gaudreau C, Gilbert H. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J Antimicrob Chemother 1997; 39: 707-12.
7. Herve J, Aissa N, Legrand P, Sorkine M, Calmette M, Santin A, et al. Campylobacter fetus meningitis in a diabetic adult cured by imipenem. Eur J Clin Microbiol Infect Dis 2004; 23: 722-4.
8. Ichiyama S, Hirai S, Minami T, Nishiyama Y, Shimizu S, Shimokata K, et al.. Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis 1998; 27: 252-5.
9. Monselise A, Blickstein D, Ostfeld I, Segal R, Weinberger M. A case of cellulitis complicating Campylobacter jejuni subsp. jejuni bacteremia and review of the literature. Eur J Clin Microbiol Infect Dis 2004; 23: 718-21.
10. Nachamkin I. Campylobacter and Arcobacter. En: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of Clinical Microbiology. Washington D.C., ASM Press, 2003, p. 902-14.
11. Pigrau C, Bartolomé R, Almirante B, Planes AM, Gavalda J, Pahissa A. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 1997; 25: 1414-20.
12. Prats G, Mirelis B, Llovet T, Muñoz C, Miró E, Navarro F. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob Agents Chemother 2000; 44: 1140-5.
13. Reimer L, Wilson M, Weinstein M. Update on detection of bacteremia and fungemia. Clin Microbial Rev 1997; 10: 444-65.
14. Tremblay C, Gaudreau C. Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother 1998; 42: 1847-9.
15. Tremblay C, Gaudreau C, Lorange M. Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Quebec, Canada, from 1983 to 2000. J Clin Microbiol 2003; 41: 463-6.